UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Gilead Sciences is implementing good security practices.
Gilead Sciences, Inc., commonly known as Gilead Sciences or Gilead (also styled GILEAD), is an American biotechnology company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. Headquartered and founded in Foster City, California, Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.
This report shows a preliminary security rating for Gilead Sciences. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
The Brazilian General Data Protection Law (Lei Geral de Proteção de Dados Pessoais or LGPD) is a ...
Outsourcing, digitization, and globalization have made vendor risk management a top priority for ...
Compare Gilead Sciences's security performance with other companies